Diakine-DK15 10 (EGFR)

N/A

Report date: 2023/03/07 15:36:01

Base Information

Drug NameDiakine-DK15 10 (EGFR)

Drug Alias NameDiakine™- DK15 10 (EGFR)

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionInterleukin 10 receptor stimulantsAnti-Epidermal growth factor receptor erbB1Interleukin-15 receptors agonists

TargetsEpidermal growth factor receptor erbB1Interleukin-2 receptorInterleukin-15 receptors

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

ATC CodeN/A